{"name":"Hatteras Venture Partners","permalink":"hatteras-venture-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/hatteras-venture-partners","homepage_url":"http://www.hatterasvp.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"1-919-484-0730","description":"Bio-pharm. focused Venture Capital","email_address":"","number_of_employees":null,"founded_year":2000,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri May 22 05:43:17 UTC 2009","updated_at":"Tue Jun 16 23:34:31 UTC 2009","overview":"<p>Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. </p>\n\n<p>Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.</p>","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/6917/46917v2-max-150x150.png"],[[250,65],"assets/images/resized/0004/6917/46917v2-max-250x250.png"],[[393,103],"assets/images/resized/0004/6917/46917v2-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"280 S. Mangum St., Suite 350","address2":"","zip_code":"27701","city":"Durham","state_code":"NC","country_code":"USA","latitude":35.9923023,"longitude":-78.9021427}],"relationships":[{"is_past":false,"title":"General Partner","person":{"first_name":"Robert A.","last_name":"Ingram","permalink":"robert-a-ingram","image":{"available_sizes":[[[123,150],"assets/images/resized/0004/6920/46920v1-max-150x150.jpg"],[[193,235],"assets/images/resized/0004/6920/46920v1-max-250x250.jpg"],[[193,235],"assets/images/resized/0004/6920/46920v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"General Partner ","person":{"first_name":"Douglas","last_name":"Reed","permalink":"douglas-reed","image":null}},{"is_past":false,"title":"General Partner ","person":{"first_name":"Kenneth","last_name":"B. Lee","permalink":"kenneth-b-lee","image":{"available_sizes":[[[150,124],"assets/images/resized/0004/6924/46924v1-max-150x150.jpg"],[[227,189],"assets/images/resized/0004/6924/46924v1-max-250x250.jpg"],[[227,189],"assets/images/resized/0004/6924/46924v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"General Partner ","person":{"first_name":"Clay","last_name":"B. Thorp","permalink":"clay-b-thorp","image":{"available_sizes":[[[150,124],"assets/images/resized/0004/6929/46929v1-max-150x150.jpg"],[[227,189],"assets/images/resized/0004/6929/46929v1-max-250x250.jpg"],[[227,189],"assets/images/resized/0004/6929/46929v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.ncbiotech.org/news_and_events/industry_news/durhams_artuslabs_lands_26m_in.html","source_description":"Durham's ArtusLabs Lands $2.6M in Venture Funding","raised_amount":2600000,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":26,"company":{"name":"ArtusLabs","permalink":"artuslabs","image":{"available_sizes":[[[150,59],"assets/images/resized/0004/5131/45131v1-max-150x150.jpg"],[[191,76],"assets/images/resized/0004/5131/45131v1-max-250x250.jpg"],[[191,76],"assets/images/resized/0004/5131/45131v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2008/06/03/spineworks-medical-raising-88m-for-spinal-devices/","source_description":"Spineworks Medical raising $8.8M for spinal devices","raised_amount":8800000,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":3,"company":{"name":"SpineAlign Medical","permalink":"spinealign-medical","image":{"available_sizes":[[[150,63],"assets/images/resized/0006/0034/60034v1-max-150x150.jpg"],[[237,101],"assets/images/resized/0006/0034/60034v1-max-250x250.jpg"],[[237,101],"assets/images/resized/0006/0034/60034v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/viamet-gets-big-pharma-support-18m-round/2009-07-07","source_description":"Viamet gets Big Pharma support in $18M round Read more: http://www.fiercebiotech.com/story/viamet-gets-big-pharma-support-18m-round/2009-07-07#ixzz0S4Hjz62O","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":7,"company":{"name":"Viamet Pharmaceuticals","permalink":"viamet-pharmaceuticals","image":{"available_sizes":[[[150,46],"assets/images/resized/0006/3580/63580v1-max-150x150.jpg"],[[250,77],"assets/images/resized/0006/3580/63580v1-max-250x250.jpg"],[[255,79],"assets/images/resized/0006/3580/63580v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/01/phasebio-pharmaceuticals-raises.html","source_description":"PhaseBio Pharmaceuticals Raises $25M in Series B Funding Round","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":7,"company":{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://olv.duke.edu/About/News/20071025085536830","source_description":"Phase Bioscience raises $6.6 million","raised_amount":6600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":24,"company":{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://findarticles.com/p/articles/mi_m0EIN/is_2007_June_7/ai_n27267020/","source_description":"Viamet Pharmaceuticals Raises $4 Million Round of Financing","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":7,"company":{"name":"Viamet Pharmaceuticals","permalink":"viamet-pharmaceuticals","image":{"available_sizes":[[[150,46],"assets/images/resized/0006/3580/63580v1-max-150x150.jpg"],[[250,77],"assets/images/resized/0006/3580/63580v1-max-250x250.jpg"],[[255,79],"assets/images/resized/0006/3580/63580v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/anulex-technologies-inc-series-e-183m/","source_description":"Anulex Technologies, Inc.: Series E $18.3M","raised_amount":18300000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":7,"company":{"name":"Anulex","permalink":"anulex","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/9175/49175v1-max-150x150.png"],[[184,50],"assets/images/resized/0004/9175/49175v1-max-250x250.png"],[[184,50],"assets/images/resized/0004/9175/49175v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/tetralogic-nabs-32m-round-lead-cancer-therapy/2010-08-10?utm_medium=rss&utm_source=rss","source_description":"TetraLogic nabs $32M round for lead cancer therapy  Read more: TetraLogic nabs $32M round for lead cancer therapy","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":10,"company":{"name":"TetraLogic Pharmaceuticals","permalink":"tetralogic-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0009/8561/98561v1-max-150x150.png"],[[250,72],"assets/images/resized/0009/8561/98561v1-max-250x250.png"],[[270,78],"assets/images/resized/0009/8561/98561v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/09/clinipace-worldwide-closes-15m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Clinipace Worldwide Closes $15M Series C Funding Round","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":27,"company":{"name":"Clinipace WorldWide","permalink":"clinipace-worldwide","image":{"available_sizes":[[[150,41],"assets/images/resized/0008/5241/85241v2-max-150x150.png"],[[203,56],"assets/images/resized/0008/5241/85241v2-max-250x250.png"],[[203,56],"assets/images/resized/0008/5241/85241v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.newsobserver.com/2012/01/05/1753645/clearside-raises-4-million-to.html","source_description":"Clearside raises $4 million to advance its eye treatment","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":5,"company":{"name":"Clearside Biomedical","permalink":"clearside-biomedical","image":null}}},{"funding_round":{"round_code":"seed","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020120120e81k1gd32&r=Rss&s=DJFVLS","source_description":"GeneCentric Takes Seed Funds From Hatteras For Lung Cancer Test","raised_amount":null,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":20,"company":{"name":"GeneCentric Diagnostics","permalink":"genecentric-diagnostics","image":null}}},{"funding_round":{"round_code":"d","source_url":"http://techcrunch.com/2012/02/29/cloud-based-file-syncing-platform-sugarsync-raises-15m-to-add-another-data-center-to-the-mix/","source_description":"Cloud-Based File Syncing Platform SugarSync Raises $15M To Add Another Data Center To The Mix","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":29,"company":{"name":"SugarSync","permalink":"sugarsync","image":{"available_sizes":[[[150,68],"assets/images/resized/0007/3438/73438v6-max-150x150.jpg"],[[250,113],"assets/images/resized/0007/3438/73438v6-max-250x250.jpg"],[[450,204],"assets/images/resized/0007/3438/73438v6-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120605e865tt70p&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120605e865tt70p%26from%3dalert%26pid%3d32","source_description":"PhaseBio Pharmaceuticals Books $23M in Third Tranche of Series B ","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":5,"company":{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.marketwire.com/press-release/coferon-inc-announces-12-million-series-b-financing-1680034.htm","source_description":"Coferon, Inc. Announces $12 Million Series B Financing ","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":16,"company":{"name":"Coferon","permalink":"coferon","image":{"available_sizes":[[[150,41],"assets/images/resized/0020/1332/201332v1-max-150x150.jpg"],[[250,69],"assets/images/resized/0020/1332/201332v1-max-250x250.jpg"],[[313,87],"assets/images/resized/0020/1332/201332v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Hatteras Venture Partners IV","funded_year":2011,"funded_month":8,"funded_day":17,"raised_amount":74000000,"raised_currency_code":"USD","source_url":"http://www.finsmes.com/2011/08/hatteras-venture-partners-holds-close-fund-iv-74m.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Hatteras Venture Partners Holds First Close Fund IV at $74M"}],"video_embeds":[],"external_links":[]}